.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Citi
McKesson
QuintilesIMS
Boehringer Ingelheim
Covington
Fish and Richardson
Moodys
Baxter
Farmers Insurance

Generated: December 16, 2017

DrugPatentWatch Database Preview

Flutamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for flutamide and what is the scope of flutamide freedom to operate?

Flutamide
is the generic ingredient in two branded drugs marketed by Schering, Actavis Labs Fl Inc, Cipla Ltd, Mylan, Par Pharm, and Sandoz, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for flutamide. Five suppliers are listed for this compound.

Pharmacology for flutamide

Medical Subject Heading (MeSH) Categories for flutamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
SandozFLUTAMIDEflutamideCAPSULE;ORAL075818-001Sep 18, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Par PharmFLUTAMIDEflutamideCAPSULE;ORAL075298-001Sep 18, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncFLUTAMIDEflutamideCAPSULE;ORAL075820-001Sep 18, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla LtdFLUTAMIDEflutamideCAPSULE;ORAL075780-001Sep 19, 2001ABRXNoYes► Subscribe► Subscribe► Subscribe
ScheringEULEXINflutamideCAPSULE;ORAL018554-001Jan 27, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
MylanFLUTAMIDEflutamideCAPSULE;ORAL076224-001May 9, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: flutamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
ScheringEULEXINflutamideCAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
ScheringEULEXINflutamideCAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
ScheringEULEXINflutamideCAPSULE;ORAL018554-001Jan 27, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Merck
Harvard Business School
Chinese Patent Office
Farmers Insurance
Boehringer Ingelheim
Cerilliant
Johnson and Johnson
Express Scripts
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot